+30.4%
GSK vs BG
+50.1%
-19.7%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.2% | -0.8% | -1.9% |
| 7D | -1.8% | +2.8% | -4.6% | -1.9% |
| 30D | -2.2% | +12.0% | -14.2% | -2.3% |
| 3M | -1.8% | -7.7% | +5.9% | -2.2% |
| 6M | -10.6% | +4.5% | -15.1% | -10.9% |
| YTD | +4.4% | +35.7% | -31.3% | +3.9% |
| 1Y | +30.4% | +50.1% | -19.7% | +30.7% |
| All | +30.4% | +50.1% | -19.7% | +30.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BG.
Daily Out/Under-Performance
Portfolio return minus BG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling